A Phase 3 Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Participants With Pulmonary Hypertension (PH) Due to Chronic Obstructive Pulmonary Disease (COPD)
Clinical trial NCT03496623 · TERMINATED
Trial details
- NCT number
- NCT03496623
- Sponsor
- United Therapeutics
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-08
- Primary completion
- 2022-10-13
- Enrollment
- 188
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.